T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes

Jeffrey Babad, Ari Geliebter, Teresa P. DiLorenzo

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations


Summary: The non-obese diabetic (NOD) mouse model of autoimmune (type 1) diabetes has contributed greatly to our understanding of disease pathogenesis and has facilitated the development and testing of therapeutic strategies to combat the disease. Although the model is a valuable immunological tool in its own right, it reaches its fullest potential in areas where its findings translate to the human disease. Perhaps the foremost example of this is the field of T-cell antigen discovery, from which diverse benefits can be derived, including the development of antigen-specific disease interventions. The majority of NOD T-cell antigens are also targets of T-cell autoimmunity in patients with type 1 diabetes, and several of these are currently being evaluated in clinical trials. Here we review the journeys of these antigens from bench to bedside. We also discuss several recently identified NOD T-cell autoantigens whose translational potential warrants further investigation.

Original languageEnglish (US)
Pages (from-to)459-465
Number of pages7
Issue number4
StatePublished - Dec 2010


  • Autoantigens
  • Autoimmune diabetes
  • Non-obese diabetic mice
  • Therapies
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes'. Together they form a unique fingerprint.

Cite this